+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026

  • Report

  • 1500 Pages
  • September 2026
  • Region: Global
  • CurrentPartnering
  • ID: 4495782
Description Jump to:
Understand how pharmaceutical and biotechnology companies structure clinical-stage partnerships using intelligence from 2,037 real-world deals.

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 provides comprehensive intelligence on 2,037 clinical-stage partnering deals, offering a detailed view of how companies structure, value and negotiate partnerships around assets in Phase I, Phase II, Phase III and later clinical development.

Clinical-stage partnering represents a critical point in the pharmaceutical development lifecycle. Assets have progressed beyond discovery and preclinical development and may have generated human safety, efficacy or proof-of-concept data, but significant clinical, regulatory and commercial risk can remain.

As assets progress through the clinic, their potential value, funding requirements, development responsibilities and negotiating dynamics can change substantially.

Clinical-stage transactions therefore often involve significant upfront consideration alongside development, regulatory and commercial milestones, royalties, equity investment and carefully defined allocation of future development and commercialization rights.

The report brings this activity together in one resource, enabling users to understand who is partnering clinical-stage assets, which companies are most active, how agreements differ by clinical phase, what financial terms have been disclosed and what can be learned from comparable transactions and real contract provisions.

Rather than simply providing a list of transactions, the report combines market-wide clinical-stage analysis with phase-specific financial benchmarking, payment-strategy analysis, leading dealmaker intelligence, detailed case studies, transaction records and access to publicly available contract documents where available.

It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, external innovation, portfolio strategy, clinical development, valuation, finance and legal teams involved in evaluating, structuring or negotiating clinical-stage partnerships.

Understand the clinical-stage partnering landscape

The report analyzes clinical-stage dealmaking from 2020 to 2026, including:

  • Trends in clinical-stage partnering by year
  • Phase I partnering activity
  • Phase II partnering activity
  • Phase III partnering activity
  • Deal type
  • Therapy area
  • Technology type
  • Most active clinical-stage dealmakers
  • Leading transactions by disclosed value
  • Pure versus multi-component partnerships
  • In-licensing and out-licensing strategies
  • How partnering changes as assets progress through clinical development
This enables users to understand where clinical-stage partnering activity is concentrated, which companies are most active and how transaction strategy evolves as assets mature.

Compare partnering at Phase I, Phase II and Phase III

Clinical stage is not a single homogeneous category.

The risk profile, available evidence, development cost and potential commercial value of a Phase I asset can differ substantially from those of a Phase II or Phase III program.

The report enables users to examine partnering activity separately across:

  • Phase I
  • Phase II
  • Phase III
  • Regulatory-stage opportunities
This stage-specific view helps users identify transactions that are more relevant to the development maturity of the asset being evaluated.

It also provides context around how deal structures and financial terms can change as clinical evidence accumulates and development risk reduces.

Understand why companies partner clinical-stage assets

For licensors and asset owners, clinical-stage partnerships can provide:

  • Funding for continued clinical development
  • Access to development and regulatory expertise
  • Late-stage clinical capabilities
  • Manufacturing infrastructure
  • Geographic expansion
  • Commercialization capabilities
  • Validation from an experienced development partner

For licensees and strategic partners, clinical-stage transactions can provide:

  • Access to assets with human clinical data
  • Opportunities to strengthen or diversify pipelines
  • Entry into new therapeutic areas
  • Access to programs closer to potential commercialization
  • Opportunities to acquire regional or global development rights
The report provides real-world examples of how these objectives are reflected in clinical-stage transaction structures.

Understand how clinical-stage agreements are structured

Clinical-stage agreements frequently combine licensing with development, regulatory, manufacturing and commercialization obligations.

Depending on the agreement and available disclosure, users can investigate areas including:

  • Licensing rights
  • Development responsibilities
  • Clinical trial responsibilities
  • Development plans and budgets
  • Regulatory responsibilities
  • Intellectual property ownership and control
  • Exclusivity
  • Governance and decision-making
  • Manufacturing and supply
  • Geographic and commercial rights
  • Co-development and co-commercialization
  • Sublicensing rights
  • Option rights
  • Term and termination provisions
The report also examines pure licensing structures versus multi-component clinical-stage partnerships, providing insight into how companies combine licensing, development and commercialization elements within a single transaction.

Benchmark clinical-stage financial terms

The report provides detailed analysis of disclosed financial terms across clinical-stage transactions.

Depending on the agreement, users can investigate:

  • Headline deal values
  • Upfront payments
  • Conditional upfront payments
  • Research and development funding
  • Licensing fees
  • Equity investment
  • Loans and convertible loans
  • Option payments
  • Development milestones
  • Regulatory milestones
  • Commercial milestones
  • Royalty arrangements
  • Supply-related payments
  • Other disclosed consideration
Users can examine the individual transactions behind these figures to understand the development phase, asset, rights, responsibilities and wider transaction context associated with the economics.

This provides more meaningful benchmarking than treating headline values or averages as standalone measures.

Compare financial terms by clinical phase

One of the report's strongest benchmarking capabilities is the ability to examine deal economics across different stages of clinical development.

Users can investigate financial terms associated with:

  • Phase I transactions
  • Phase II transactions
  • Phase III transactions

The report analyzes elements including:

  • Headline values
  • Upfront payments
  • Milestone payments
  • Royalty rates
This enables users to compare a proposed transaction with deals involving assets at a more relevant stage of development rather than relying on a single clinical-stage benchmark.

Understand how value changes as clinical evidence develops

As an asset progresses through clinical development, additional evidence can influence both perceived risk and negotiating leverage.

The report provides context around how deal economics may evolve alongside:

  • Initial human safety data
  • Early efficacy signals
  • Proof-of-concept
  • Later-stage clinical validation
  • Regulatory progression
  • Commercial readiness
This helps users understand how companies have allocated upfront commitment and future value across transactions at different points in clinical development.

Identify relevant comparable clinical-stage transactions

Finding appropriate comparables is central to meaningful clinical-stage benchmarking.

The report enables users to investigate transactions according to factors including:

  • Company
  • Clinical phase
  • Therapy area
  • Technology
  • Deal type
  • Financial structure
  • Headline value
  • Contract availability
This allows users to move from the wider clinical-stage landscape towards a more focused group of transactions that more closely reflect the asset and development stage being evaluated.

Identify leading clinical-stage dealmakers and prospective partners

The report identifies the Top 25 most active clinical-stage dealmakers and provides transaction histories that enable users to investigate their previous activity.

This can help users identify:

  • Companies actively seeking clinical-stage assets
  • Prospective licensing and development partners
  • Organizations repeatedly active at particular clinical stages
  • Companies interested in specific technologies or therapeutic areas
  • Dealmakers with experience in clinical-stage transaction structures
  • Competitors building pipelines through external clinical assets
  • Relevant precedent transactions
For companies seeking a partner, previous clinical-stage deal activity can provide valuable evidence of which organizations have demonstrated an appetite for comparable opportunities.

Support search and evaluation and portfolio strategy

Clinical-stage partnering activity provides an important indicator of where companies are willing to commit substantial development resources and capital.

The report enables users to investigate which organizations are:

  • In-licensing clinical-stage assets
  • Expanding into new therapeutic areas
  • Adding later-stage programs to pipelines
  • Acquiring rights to assets with emerging clinical validation
  • Using partnerships to fill portfolio gaps
  • Seeking opportunities closer to potential commercialization
This makes the report particularly relevant for search and evaluation, external innovation, portfolio strategy and competitive intelligence teams.

Learn from real-world clinical-stage contracts

Where publicly available, the report provides access to underlying contract documents for selected clinical-stage transactions.

These agreements can provide substantially more detail than company announcements alone, enabling users to examine how partners have documented matters including:

  • Rights granted and retained
  • Clinical development obligations
  • Regulatory responsibilities
  • Intellectual property
  • Exclusivity
  • Upfront and milestone payments
  • Royalty provisions
  • Governance
  • Manufacturing and commercialization rights
  • Audit provisions
  • Confidentiality and publication
  • Change-of-control provisions
  • Termination and continuing rights
For teams preparing or negotiating a clinical-stage agreement, access to real contract language provides valuable insight into how comparable relationships have been structured in practice.

Comprehensive clinical-stage deal directory

The report includes a comprehensive directory of 2,037 clinical-stage pharmaceutical and biotechnology partnering deals from 2020 to 2026.

Deals can be investigated by:

  • Company
  • Clinical phase
  • Deal type
  • Therapy area
  • Technology type
  • Financial terms
  • Contract availability
Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.

Who should use this report?

Business Development and Licensing teams

Identify prospective partners, comparable clinical-stage transactions and relevant deal structures.

Search and Evaluation and External Innovation teams

Understand which companies are actively pursuing Phase I, Phase II and Phase III assets across relevant therapeutic and technology areas.

Biotechnology Companies Seeking Partners

Identify organizations with demonstrated experience partnering around clinical-stage assets.

Portfolio and Corporate Strategy teams

Understand how companies are using clinical-stage transactions to strengthen pipelines and fill development gaps.

Clinical Development and R&D Strategy teams

Examine how development responsibilities and future rights are shared across comparable partnerships.

Valuation and Finance teams

Investigate phase-specific upfronts, milestones, royalties and comparable transactions to support clinical-stage asset assessment.

Competitive and Market Intelligence teams

Track strategic interest across companies, technologies, therapeutic areas and clinical stages.

Legal and Transaction teams

Review publicly available agreements and real-world clauses to support structuring and negotiation of clinical-stage partnerships.

Turn market-wide clinical-stage intelligence into company-specific insight

For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.

The briefing applies the underlying clinical-stage partnering intelligence to the customer's own asset, development program or partnering objectives.

Depending on requirements, this can include relevant Phase I, Phase II or Phase III comparable transactions, prospective partners, competitor activity, stage-specific financial benchmarks, deal structures, contract insights and other intelligence selected specifically for the client's situation.

Table of Contents

Executive SummaryChapter 1 - Introduction
Chapter 2 - Why do companies partner clinical stage compounds?
2.1. Introduction
2.2. The role of clinical stage partnering
2.2.1. In-licensing at clinical stage
2.2.2. Out-licensing at clinical stage
2.3. Difference between phase I, II and III stage deals
2.4. Reasons for entering into clinical stage partnering deals
2.4.1. Licensors reasons for entering clinical stage deals
2.4.2. Licensees reasons for entering clinical stage deals
2.5. The future of clinical stage partnering deals
Chapter 3 - Clinical stage deal strategies and structure
3.1. Introduction
3.2. At what stage do companies partner?
3.2.1. Partnering early in pharmaceutical/biotech
3.2.1.1. Discovery and preclinical stage partnering case studies
3.2.1.1.a. Case study 1
3.2.1.1.b. Case study 2
3.2.1.1.c. Case study 3
3.2.1.1.d. Case study 4
3.2.2. Partnering later in pharmaceutical/biotech
3.2.2.1. Clinical stage partnering case studies
3.2.2.1.a. Case study 5
3.2.2.1.b. Case study 6
3.2.2.1.c. Case study 7
3.2.2.1.d. Case study 8
3.3. Early and later stage partnering - a risk/cost comparison
3.4. What do companies spend on clinical stage partnering?
3.5. Pure versus multi-component partnering deals
3.6. Pure licensing agreement structure
3.6.1. Example pure licensing agreements
3.6.1.a. Case study 9
3.6.1.b. Case study 10
3.7. Multicomponent clinical stage partnering agreements
3.7.1. Example multicomponent clinical stage clauses
3.7.1.a. Case study 11
Chapter 4 - Clinical stage partnering payment strategies
4.1. Introduction
4.2. Clinical stage payment strategies
4.3. Payment options
4.3.1. Headline values
4.3.2. Upfront payments
4.3.2.1. Conditionality of upfront payments
4.3.3. Loans
4.3.4. Convertible loans
4.3.5. Equity
4.3.6. R&D funding
4.3.7. Licensing fees
4.3.8. Milestone payments
4.3.9. Royalty payments
4.3.9.1. Issues affecting royalty rates
4.3.9.2. Royalties on combination products
4.3.9.2.a. Case study 12
4.3.9.3. Guaranteed minimum/maximum annual payments
4.3.9.4. Royalty stacking
4.3.9.5. Royalties and supply/purchase contracts
4.3.10. Quids
4.3.11. Option payments
Chapter 5 - Trends in clinical stage deal making
5.1. Introduction
5.2. Clinical stage partnering over the years
5.2.1. Trends in phase I deals since 2020
5.2.1.1. Attributes of phase I deals
5.2.2. Trends in phase II deals since 2020
5.2.2.2. Attributes of phase II deals
5.2.3. Trends in phase III deals since 2020
5.2.3.1. Attributes of phase III deals
5.3. Clinical stage partnering by deal type
5.4. Clinical stage partnering by disease type
5.5. Partnering by clinical stage technology type
5.6. Clinical stage partnering by most active company since 2020
Chapter 6 - Payment terms for clinical stage partnering
6.1. Introduction
6.2. Guidelines for clinical stage payment terms
6.2.1. Upfront payments
6.2.2. Milestone payments
6.2.3. Royalty payments
6.3. Clinical stage payment terms - deal data analysis
6.3.1. Public data
6.3.2. Survey data
6.4. Payment terms analysis
6.4.1. Clinical stage partnering headline values
6.4.2. Clinical stage deal upfront payments
6.4.3. Clinical stage deal milestone payments
6.4.4. Clinical stage royalty rates
6.5 Clinical stage median financials
6.5.1. Clinical stage headline value
6.5.2. Clinical stage upfront value
6.5.3. Clinical stage milestone value
6.5.4. Clinical stage royalty value
Chapter 7 - Leading clinical stage deals
7.1. Introduction
7.2. Top clinical stage deals by value
Chapter 8 - Top 25 most active clinical stage dealmakers
8.1. Introduction
8.2. Top 25 most active clinical stage dealmakers
Chapter 9 - Clinical stage partnering contracts directory
9.1. Introduction
9.2. Clinical stage deals with contracts since 2020
Chapter 10 - Clinical stage deal making by development stage
10.1. Introduction
10.2. Deals by clinical stage
  • Phase II
  • Regulatory
  • Appendix 1 - Clinical stage dealmaking by companies A-Z
  • Appendix 3 - Clinical stage dealmaking by stage of development
  • Appendix 5 - Clinical stage dealmaking by technology type
Table of figures
Figure 1: Definition of clinical phases in dealmaking
Figure 2: Components of the pure licensing deal structure
Figure 3: Payment options for clinical stage partnering deals
Figure 4: Issues affecting royalty rates
Figure 5: Clinical stage partnering by deal type since 2020
Figure 6: Clinical stage partnering by disease type since 2020
Figure 7: Clinical stage partnering by technology type since 2020
Figure 8: Top 25 most active clinical stage dealmakers, 2020 - 2025
Figure 9: Review of upfront payments for clinical stage deals
Figure 10: Review of milestone payments for clinical stage deals
Figure 11: Review of royalty payments for clinical stage deals
Figure 12: Clinical stage deals with a headline value
Figure 13: Clinical stage deals with an upfront value
Figure 14: Clinical stage deals with a milestone value
Figure 15: Clinical stage deals with a royalty rate value
Figure 16: Top clinical stage deals by value since 2020
Figure 17: Most active clinical stage dealmakers 2020 - 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 1cBio
  • 1ST Biotherapeutics
  • 2cureX
  • 3D Medicines
  • 3M
  • 3SBio
  • 4D Molecular Therapeutics
  • 4D Pharma
  • 4Living Biotech
  • 4P-Pharma
  • 4P Therapeutics
  • 4SC
  • 9 Meters Biopharma
  • Aadi Bioscience
  • AazeinTx
  • AB2 Bio
  • Abbisko Therapeutics
  • Abbvie
  • Abcam
  • ABEC
  • AbelZeta Pharma
  • Abeona Therapeutics
  • Abingworth Life Sciences
  • ABL Bio
  • ABLi Therapeutics
  • Abliva
  • ABVC BioPharma
  • Academic Breast Cancer Consortium
  • ACADIA Pharmaceuticals
  • Acasti Pharma
  • Accro Bioscience
  • Accure Therapeutics
  • Acelrx Pharmaceuticals
  • Acelyrin
  • Acepodia
  • Acer Therapeutics
  • Achilles Therapeutics
  • Acibadem University
  • AC Immune
  • Aclarion
  • Aclaris Therapeutics
  • Aclipse Therapeutics
  • Acrivon Therapeutics
  • Actinium Pharmaceuticals
  • ActualEyes
  • Actuate Therapeutics
  • Acturum Life
  • Actym Therapeutics
  • Acumen Pharmaceuticals
  • Adagene
  • Adagio Therapeutics
  • Adamis Pharmaceuticals
  • Adaptimmune
  • Adaptive Phage Therapeutics
  • ADC Therapeutics
  • Addario Lung Cancer Medical Institute
  • ADEL
  • Adhera Therapeutics
  • Adial Pharmaceuticals
  • Adimune
  • Adiso Therapeutics
  • Adjuvance Technologies
  • Adlai Nortye
  • adMare BioInnovations
  • Adneuris Therapeutics
  • Advaccine Biotechnology
  • Advanced Regenerative Manufacturing Institute
  • Advanced Technology International
  • Advanz Pharma
  • Advaxis
  • Advent International
  • Adverum Biotechnologies
  • Aeglea BioTherapeutics
  • Aelix Therapeutics
  • Aerpio Pharmaceuticals
  • AffaMed Therapeutics
  • Affibody
  • Affimed Therapeutics
  • AFFiRiS
  • AGC Biologics
  • Agenus Bio
  • Agilent Technologies
  • Agility Life Sciences
  • Agios Pharmaceuticals
  • AgonOx
  • Ahngook Pharmaceuticals
  • AIM ImmunoTech
  • AimMax Therapeutics
  • AiPharma Global Holdings
  • AirNexis Therapeutics
  • Ajinomoto Bio-Pharma Services
  • AJU Pharma
  • Akamis Bio
  • Akari Therapeutics
  • Akebia Therapeutics
  • Akeso Biopharma
  • AKL Research and Development
  • Akron Biotechnology
  • Akston Biosciences
  • Albany Molecular Research
  • Albert Einstein College of Medicine
  • Alchemab Therapeutics
  • Aldevron
  • Alector
  • Alesta Therapeutics
  • Alexion Pharmaceuticals
  • Alfasigma
  • Algernon Pharmaceuticals
  • Alida Biosciences
  • Aligos Therapeutics
  • Alkem Laboratories
  • Allarity Therapeutics
  • Allecra Therapeutics
  • Allegro Ophthalmics
  • Alliance Foundation Trials
  • Alligator Bioscience
  • Allist Pharma
  • Allogene Therapeutics
  • Allorion Therapeutics
  • Almac Group
  • Almirall
  • Alnylam Pharmaceuticals
  • Alopexx
  • Alphamab Biopharmaceuticals
  • Alphamab Oncology
  • Alpha Tau Medical
  • Alpine Immune Sciences
  • Altasciences
  • Altimmune
  • Altum Pharmaceuticals
  • Alume Biosciences
  • Alumis
  • Alvogen
  • ALX Oncology
  • Alzamend Neuro
  • AlzeCure Pharma
  • Alzheimer's Drug Discovery Foundation
  • Alzheon
  • AM-Pharma
  • AmacaThera
  • Amazon Web Services
  • Ambiopharm
  • American Lung Association
  • American Renal Associates
  • Amgen
  • Amicus Therapeutics
  • AmMax Bio
  • Amneal Pharmaceuticals
  • AMO Pharma
  • Amphastar Pharmaceuticals
  • Amplia Therapeutics
  • Amplyx Pharmaceuticals
  • Amylyx Pharmaceuticals
  • Amyndas Pharmaceuticals
  • Amytrx Therapeutics
  • AN2 Therapeutics
  • ANANDA Scientific
  • AnaptysBio
  • Andelyn Biosciences
  • Angelini Pharma
  • AnGes MG
  • Angiex
  • Angion Biomedica
  • Angle
  • AnHeart Therapeutics
  • Ankyra Therapeutics
  • AnnJi Pharmaceutical
  • Annovis Bio
  • Antares Therapeutics
  • Antengene
  • Anteris Bio
  • Antharis Therapeutics
  • Antibe Therapeutics
  • Antios Therapeutics
  • AOBiome Therapeutics
  • Apeiron Biologics
  • Apellis Pharmaceuticals
  • Apexian Pharmaceuticals
  • Apexigen
  • Aphex BioCleanse Systems
  • Apollomics
  • Apollo Therapeutics
  • Appili Therapeutics
  • Applied Biology
  • Applied Therapeutics
  • Aprea Therapeutics
  • AprilBio
  • Aptinyx
  • Aptose Biosciences
  • Aramis Biotechnologies
  • Aravive Biologics
  • Arbor Biotechnologies
  • Arbormentis
  • Arbutus
  • Arcellx
  • Archeus Technologies
  • Arch Oncology
  • Arctic Therapeutics
  • Arctic Vision
  • Arcturus Therapeutics
  • Arcus Biosciences
  • Arecor
  • Arecor Therapeutics
  • Arena Pharmaceuticals
  • Argo Biopharma
  • Ariana Pharma
  • AriBio
  • Ariceum Therapeutics
  • Aridis Pharmaceuticals
  • ARISE MD Integrative Medicine & Surgery
  • Aristea Therapeutics
  • Armata Pharmaceuticals
  • ArriVent Biopharma
  • Arrowhead Pharmaceuticals
  • ARTBIO
  • Artelo Biosciences
  • Artios Pharma
  • Artiva Biotherapeutics
  • ARTMS Product
  • Aruvant Sciences
  • Arvinas
  • Asahi Kasei
  • Asana Biosciences
  • Asarina Pharma
  • Ascendant Health Sciences
  • Asceneuron
  • Ascentage Pharma
  • Ascidian Therapeutics
  • Asher Bio
  • Asher Biotherapeutics
  • Ashion Analytics
  • Asieris MediTech
  • ASKA Pharmaceuticals
  • Aslan Pharma
  • Aspen Neuroscience
  • Assembly Biosciences
  • Association for Frontotemporal Degeneration
  • Astellas Pharma
  • Astellas Pharma US
  • Astex Pharmaceuticals
  • AstraZeneca
  • Astria Therapeutics
  • Asymchem Laboratories
  • Atara Biotherapeutics
  • Atea Pharmaceuticals
  • Athena Pharmaceutiques
  • Athira Pharma
  • ATMA Journey Centers
  • Atom Therapeutics
  • Atsena Therapeutics
  • aTyr Pharma
  • Auditus
  • AUM Biosciences
  • Aurobindo Pharma
  • Australian and New Zealand Children’s Haematology / Oncology Group
  • Australian Medical Research Institute
  • Autism Impact Fund
  • Autobahn Therapeutics
  • Autonomous Therapeutics
  • Avalo Therapeutics
  • Avance Clinical
  • Avania
  • Avantor
  • Avecho Biotechnology
  • Avenue Therapeutics
  • Avenzo Therapeutics
  • AVEO Oncology
  • Aveta Biomics
  • AviadoBio
  • Avid Bioservices
  • AVM Biotechnology
  • Awakn Life Sciences
  • Axovant Gene Therapies
  • Axovia Therapeutics
  • Axsome Therapeutics
  • Ayala Pharmaceuticals
  • Azura Ophthalmics
  • Azurity Pharmaceuticals
  • AzurRx BioPharma
  • Bachem
  • Baili Biopharmaceutical
  • Baliopharm
  • Banner Alzheimer's Institute
  • Barbara Ann Karmanos Cancer Institute
  • Basilea Pharmaceutica
  • Battelle
  • Bausch Health Companies
  • Bavarian Nordic
  • Baxter International
  • Bayer
  • Baylor College of Medicine
  • BCM Europe
  • Beam Therapeutics
  • BeiGene
  • Beijing InnoCare Pharma
  • Beijing Tide Pharmaceutical
  • Belle.ai
  • Benuvia Therapeutics
  • BeOne Medicines
  • BerGenBio
  • Be The Match BioTherapies
  • BetterLife Pharma
  • Better Therapeutics
  • Beverly Hills Cancer Center
  • Beyond Cancer
  • Bharat Biotech
  • Bial
  • Bicycle Therapeutics
  • Bill and Melinda Gates Foundation
  • Binex
  • Bio-Techne
  • Bio-Thera Solutions
  • BioAegis Therapeutics
  • BioAge Labs
  • BioAtla
  • Biocept
  • BioCity Biopharma
  • Biocodex
  • Biocon
  • BioCorRx
  • BioCryst Pharmaceuticals
  • Biodesix
  • Biodexa Pharmaceuticals
  • Biodextris
  • BioEclipse Therapeutics
  • BioElpida
  • Biofabri
  • Bioforum
  • Biofourmis
  • Biogen
  • Biohaven Pharmaceuticals
  • BioInvent
  • BioKey
  • Biolexis
  • BiolineRX
  • BioLink Life Sciences
  • Biological E
  • BioMarin Pharmaceutical
  • BioMatrix Specialty Pharmacy
  • Biomedical Advanced Research and Development Authority
  • BioMed Valley Discoveries
  • Biomerica
  • Biomica
  • Biomunex Pharmaceuticals
  • BiomX
  • Biond Biologics
  • Bioniz Therapeutics
  • BioNova Pharmaceuticals
  • BioNTech
  • BioPharma Services
  • bioRASI
  • BioRestorative Therapies
  • BioSenic
  • BioSight
  • Biosion
  • Biosplice
  • Biossil
  • Biotechnology Industry Research Assistance Council
  • Biotheus
  • BioVaxys
  • BioVectra
  • BioVersys
  • BioVie
  • BioXcel
  • BJ Bioscience
  • Black Diamond Therapeutics
  • Blackstone
  • Bliss Biopharmaceutical
  • Bluebird Bio
  • Blue Note Therapeutics
  • Blueprint Medicines
  • BlueWhale Bio
  • BNC Korea
  • BobcatBio
  • Boehringer Ingelheim
  • Bold Therapeutics
  • Bolt Biotherapeutics
  • Bone Biologics
  • Bone Therapeutics
  • BOOST Pharma
  • BostonGene
  • Boston Immune Technologies and Therapeutics
  • Boston Pharmaceuticals
  • Botanix Pharmaceuticals
  • Boundless Bio
  • Bpifrance
  • Brainomix
  • Braintree Laboratories
  • Braveheart Bio
  • BriaCell Therapeutics
  • Brickell Biotech
  • BridgeBio Pharma
  • Bridge Biotherapeutics
  • Brigham and Women's Hospital
  • Bright Minds Biosciences
  • BrightPath Biotherapeutics
  • Brii Biosciences
  • Bristol-Myers Squibb
  • Brown University
  • BryoLogyx
  • Burning Rock
  • Butantan Institute
  • Byondis
  • C4 Therapeutics
  • Cabaletta Bio
  • Cadila Pharmaceuticals
  • Cadrenal Therapeutics
  • Caeregen Therapeutics
  • Calder Biosciences
  • Calian Group
  • Calico
  • Calidi Biotherapeutics
  • California Institute for Regenerative Medicine
  • Calithera Biosciences
  • Can-Fite BioPharma
  • Canadian Neuromuscular Disease Registry
  • CanariaBio
  • Cancer Focus Fund
  • Cancer Prevention and Research Institute of Texas
  • Cancer Research UK
  • Cancer Targeted Technology
  • Candel Therapeutics
  • Cantargia
  • Cantex Pharmaceuticals
  • Capillary Biomedical
  • Capricor Therapeutics
  • CARB-X
  • Cardiff Oncology
  • Cardinal Health
  • Care Access Research
  • Caring Cross
  • Caris Life Sciences
  • Carisma Therapeutics
  • Carrick Therapeutics
  • CARsgen
  • Cartesian Therapeutics
  • CASI Pharmaceuticals
  • Cassava Sciences
  • Castle Creek Biosciences
  • Catabasis Pharmaceuticals
  • Catalent
  • Catalyst Clinical Research
  • Catalyst Pharmaceuticals
  • CCT Research
  • Ceapro
  • Cedar Clinical Research
  • Cedars-Sinai Medical Center
  • Celcuity
  • Celiac Disease Foundation
  • Cell and Gene Therapy Catapult
  • Cellares
  • Cell Cure Neurosciences
  • Cellectar Biosciences
  • Cellectis
  • Cellenkos
  • Cellino Biotech
  • Cellipont Bioservices
  • Cellistic
  • CellType
  • Cellular Biomedicine
  • CellVax Therapeutics
  • Celonic
  • Celyn Therapeutics
  • Cend Therapeutics
  • Center for Breakthrough Medicines
  • Centers for Disease Control and Prevention
  • Centogene
  • Cerecor
  • CG Oncology
  • Charak Foundation
  • Charles River Laboratories
  • Checkmate Pharmaceuticals
  • Chemomab Therapeutics
  • Chengdu Kanghua Biological Products
  • Chi-Med
  • Chiesi Farmaceutici
  • Children's Hospital Boston
  • Children's Hospital Los Angeles
  • Chimagen Biosciences
  • Chime Biologics
  • Chimeric Therapeutics
  • China Medical System
  • China Resources Sanjiu Medical and Pharmaceutical
  • Chipscreen NewWay Biosciences
  • Chong Kun Dang
  • Chongqing Yao Pharmaceutical
  • Chugai Pharmaceutical
  • CicloMed
  • Cidara Therapeutics
  • Cincinnati Children’s Hospital Medical Center
  • Circio
  • Circuit Clinical
  • CIRION BioPharma Research
  • City of Hope
  • Clarity Pharmaceuticals
  • ClearB Therapeutics
  • Clearmind Medicine
  • Cleave Therapeutics
  • Cleveland Clinic
  • Clinical Trial and Consulting Services
  • Clinica Universidad Navarra
  • Clinilabs
  • Clinlogix
  • CloudCath
  • Clover Biopharmaceuticals
  • Clovis Oncology
  • Cmed
  • CMG Pharmaceutical
  • CND Life Sciences
  • CNS Pharmaceuticals
  • Coalition for Epidemic Preparedness Innovations
  • Cobra Biologics
  • Cocrystal Pharma
  • Codagenix
  • Codexis
  • Coeptis Pharmaceuticals
  • Coeptis Therapeutics
  • Cognition Therapeutics
  • Cognito Therapeutics
  • Coherus Biosciences
  • Columbia University
  • Combangio
  • Commonwealth of Pennsylvania
  • Compass Therapeutics
  • Compugen
  • Concentric Analgesics
  • Conduit Pharmaceuticals
  • Confo Therapeutics
  • Connect
  • ConSynance Therapeutics
  • Context Therapeutics
  • Contineum Therapeutics
  • ContraFect
  • Convergent Therapeutics
  • COPD Foundation
  • CORAT Therapeutics
  • Corbus Pharmaceuticals
  • CordenPharma
  • Corden Pharma
  • CoreRx Pharma
  • Cornell University
  • Corpometria Institute
  • Cortice Biosciences
  • CORXEL Pharmaceuticals
  • Cosmo Pharmaceuticals
  • COVAXX
  • Creapharm
  • Crescendo Biologics
  • Crescent Biopharma
  • Crinetics
  • Criterium
  • Critical Path Institute (C-Path)
  • Cromos Pharma
  • CromSource
  • CryoPort
  • CSIR-Central Drug Research Institute
  • CSL
  • CSL Behring
  • CSPC Megalith Biopharmaceutical
  • CSPC Pharmaceutical Group
  • CS Pharmaceuticals
  • CStone Pharmaceuticals
  • Cue Biopharma
  • Cugene
  • Cullinan Oncology
  • Cullinan Therapeutics
  • Curasight
  • Curatis
  • Curavit Clinical Research
  • CUREator
  • Curebase
  • Cure Stat Rx
  • Curetis
  • CureVac
  • Cureverse
  • Curis
  • Curium
  • Curon Biopharmaceutical
  • Curtana Pharmaceuticals
  • CyanVac
  • Cybin
  • Cybrexa Therapeutics
  • Cyclerion Therapeutics
  • Cyclotek
  • Cyprium Therapeutics
  • Cyrano Therapeutics
  • Cystic Fibrosis Foundation
  • Cytiva
  • CytoAgents
  • Cytodyn
  • Cytokinetics
  • CytoSite Bio
  • Cytovance Biologics
  • Cytovation
  • D&D Pharmatech
  • Daewoong Pharmaceutical
  • Daiichi Sankyo
  • Dalton Pharma Services
  • Dana-Farber Cancer Institute
  • Danish Cancer Society Research Center
  • Dare Bioscience
  • Day One Biopharmaceuticals
  • Debiopharm
  • Defender Pharmaceuticals
  • Defense Health Agency (US)
  • Denovo Biopharma
  • Department of Defense
  • Department of Veterans Affairs
  • Dermapharm
  • Dermata Therapeutics
  • Dermavant Sciences
  • Develco Pharma
  • Deverra Therapeutics
  • Diaccurate
  • Diakonos Oncology
  • Dialco Medical
  • Diamond Therapeutics
  • Diamyd Medical
  • Dianthus Therapeutics
  • Dicerna Pharmaceuticals
  • Diffusion Pharmaceuticals
  • Dimerix Biosciences
  • Diopsys
  • Dispatch Bio
  • Diversigen
  • Dizal Pharmaceutical
  • Dong-A ST
  • Dr. Falk Pharma
  • Dr. Reddy's Laboratories
  • Dragonfly Therapeutics
  • Dren Bio
  • DRI Capital
  • DRI Healthcare
  • Drug Farm
  • Drugs for Neglected Diseases Initiative
  • DSG
  • DualityBio
  • Duchenne UK
  • Duke-NUS Graduate Medical School Singapore
  • Duke Clinical Research Institute (DCRI)
  • Duke University
  • Dutch Emotional Brain
  • DyDo Pharma
  • Dynacure
  • DynamiCure Biotechnology
  • Dynavax Technologies
  • DynPort Vaccine Company
  • Eagle Pharmaceuticals
  • EA Pharma
  • Eccogene
  • Eckert & Ziegler
  • Eczacıbasi-Monrol
  • Edgewise Therapeutics
  • Edith Wolfson Medical Center
  • Efemoral Medical
  • eFFECTOR Therapeutics
  • Eiger BioPharmaceuticals
  • Eikonizo Therapeutics
  • Eikon Therapeutics
  • EIP Pharma
  • Eisai
  • Elanco
  • Eledon Pharmaceuticals
  • Elevar Therapeutics
  • ElevateBio
  • Elevation Oncology
  • Elicio Therapeutics
  • Eli Lilly
  • Elixirgen
  • Ellipses Pharma
  • Eloxx Pharmaceuticals
  • Elpiscience
  • Eluminex Biosciences
  • Emerald Innovations
  • Emergent BioSolutions
  • Emergex Vaccines
  • Emmes Group
  • Empirico
  • Emtora Biosciences
  • EmVenio Research
  • ENA Respiratory
  • ENCell
  • Endo International
  • Endpoint Health
  • ENDRA Life Sciences
  • Energenesis Biomedical
  • Enlivex
  • Ensysce Biosciences
  • Entera Bio
  • Enterin
  • Enterome Bioscience
  • Entheon Biomedical
  • Entos Pharmaceuticals
  • Enveric Biosciences
  • Enzychem Lifesciences
  • EpicentRx
  • Epicrispr Biotechnologies
  • Epic Sciences
  • EQRx
  • Equillium
  • Equinox Science
  • Er-Kim
  • Erasca
  • Erasmus University Medical Center
  • ESSA Pharma
  • ES Therapeutics
  • Ethris
  • Eucure Biopharma
  • Eunice Kennedy Shriver Institute of Child Health and Human Development
  • Eureka Eurostars
  • Eurocine Vaccines
  • Eurofins Scientific
  • European Biomedical Research Institute of Salerno
  • European Commission
  • European Union
  • EUSA Pharma
  • Evaxion Biotech
  • Everest Medicines
  • Evergreen Theragnostics
  • Evergreen Therapeutics
  • EverInsight Therapeutics
  • Eversana
  • Evexta Bio
  • Evogene
  • Evolution Research Group
  • Evommune
  • Evon Medics
  • Evopoint Biosciences
  • Evotec
  • Ewopharma
  • Exact Therapeutics
  • Exagen Diagnostics
  • Exai Bio
  • Excellmab
  • ExCellThera
  • Excision BioTherapeutics
  • Exelixis
  • Exothera
  • Eyenovia
  • EyePoint Pharmaceuticals
  • F-Star Therapeutics
  • F4 Pharma
  • Factor Bioscience
  • Famy Life Sciences
  • Fareva Holding
  • FarmaMondo Group
  • Feinstein Institute for Medical Research
  • Ferrer
  • Ferring Pharmaceuticals
  • Fibrogen
  • Filament Health
  • Finch Therapeutics
  • Firefly Neuroscience
  • First Wave Bio
  • FivepHusion
  • Flare Therapeutics
  • Flatiron Health
  • Florence
  • Fluence
  • Food and Drug Administration (FDA)
  • ForDoz Pharma
  • Foreseen Biotechnology
  • Foresee Pharmaceuticals
  • Forge Biologics
  • FORMA Therapeutics
  • Formation Bio
  • Formosa Pharmaceuticals
  • Formycon
  • Fortis Therapeutics
  • Fortrea
  • Fosun Pharmaceutical
  • Fosun Wanbang
  • Foundation Medicine
  • Fox Chase Cancer Center
  • Fred Hutchinson Cancer Research Center
  • Freeline Therapeutics
  • Fresh Tracks Therapeutics
  • Freya Pharma Solutions
  • Frontage Clinical Services
  • Frontier Biotech
  • Fujifilm
  • Fujifilm Diosynth Biotechnologies
  • Fujirebio Diagnostics
  • Fuji Yakuhin
  • Fulcrum Therapeutics
  • Fusion Pharmaceuticals
  • FutureChem
  • FyoniBio
  • G1 Therapeutics
  • G42 Healthcare
  • Gain Therapeutics
  • Galapagos
  • Galecto
  • Galera Therapeutics
  • Galimedix Therapeutics
  • Gamaleya National Center
  • Gan & Lee
  • GATC Health
  • Gates Medical Research Institute
  • Gateway for Cancer Research
  • GAVI Alliance
  • GC Biopharma
  • GC Pharma
  • GE Healthcare
  • GEICAM
  • Gemelli Teaching Hospital
  • Gemini Therapeutics
  • GEMMA Biotherapeutics
  • GEn1E Lifesciences
  • Genascence
  • Genelux
  • Genentech
  • Geneoscopy
  • Genethon
  • Genetika+
  • Geneva Foundation
  • Genezen
  • Genfit
  • GenFleet Therapeutics
  • Genhouse Bio
  • Genome and Company
  • Genomind
  • Genosity
  • Genprex
  • Genrix Bio
  • Gensci
  • GenScript Biotech
  • GenScript ProBio
  • George Clinical
  • George Medicines
  • Georgetown University
  • George Washington University
  • Georgiamune
  • GeoVax
  • German Center for Infection Research
  • German Federal Ministry of Education and Research
  • German Government
  • Giiant Pharma
  • GI Innovation
  • Gilead Sciences
  • Gilgamesh Pharmaceuticals
  • Glaukos
  • Glenmark Pharmaceuticals
  • Glenmark Pharmaceuticals S.A.
  • Global Coalition for Adaptive Research
  • Global Medical Solutions
  • Gloria Biosciences
  • GlycoMimetics
  • GlycoNex
  • Glycostem Therapeutics
  • Glycotope Biotechnology
  • GOG Foundation
  • Gore Range Capital
  • Gossamer Bio
  • Government of Canada
  • Government of France
  • Government of India
  • Government of Israel
  • Government of Netherlands
  • Government of South Korea
  • Government of Switzerland
  • GPCR Therapeutics
  • Granata Bio
  • Grand River Aseptic Manufacturing
  • Graviton Bioscience
  • Great Ormond Street Hospital (GOSH)
  • Green Valley Pharmaceutical
  • Greenwich LifeSciences
  • Grey Wolf Therapeutics
  • Grifols
  • GRIN Therapeutics
  • Gritstone Bio
  • Groupe d'OncologieRadiothérapie Tête Et Cou
  • Groupe Francophone des Myélodysplasies
  • Grunenthal
  • GSK
  • GT Biopharma
  • GT Medical Technologies
  • Guangzhou Fermion Technology
  • Guardant Health
  • Gubra
  • Hadassah Medical Center
  • HaemaLogiX
  • Haisco Pharmaceutical
  • Halix
  • Halozyme Therapeutics
  • Halucenex Life Sciences
  • HanchorBio
  • Hancock Jaffe Laboratories
  • Handok Pharmaceuticals
  • Hangzhou Highlightll Pharmaceutical
  • Hangzhou Zhongmei Huadong Pharmaceutical
  • Hanmi Pharmaceutical
  • Hansa Biopharma
  • Harbour Biomed
  • Harmony Biosciences
  • Harpoon Therapeutics
  • Harrow Health
  • Harvard Medical School
  • Hasten Biopharmaceutic
  • Haystack Oncology
  • HCW Biologics
  • Healis Therapeutics
  • Healthcare Royalty Partners
  • Health Hope Pharma
  • Healx
  • Helmholtz Zentrum Munchen
  • Helocyte
  • HELP Therapeutics
  • Helsinn Therapeutics
  • Hemispherian
  • Hemogenyx
  • Hengenix Biotech
  • Henlius Biotech
  • Hepalys Pharma
  • Hepion Pharmaceuticals
  • HepQuant
  • HiberCell
  • HIBio
  • HiFiBio
  • Highlight Therapeutics
  • Hikma Pharmaceuticals
  • HilleVax
  • Hillhurst Biopharmaceuticals
  • HistoIndex
  • HK inno.N
  • HMNC Brain Health
  • Hoffmann La Roche
  • Hookipa Pharma
  • Horizon Europe
  • Horizon Therapeutics
  • Hoth Therapeutics
  • Huadong Medicine
  • Hubble Therapeutics
  • Hubro Therapeutics
  • Humanigen
  • Hummingbird Bioscience
  • Hutchmed
  • Huyabio International
  • Hvidovre Hospital
  • hVIVO
  • Hygieia
  • Hygtia Therapeutics
  • Hyloris Pharmaceuticals
  • Hypospray Pharma
  • I-mab
  • IACTA Pharmaceuticals
  • IAMA Therapeutics
  • Iambic Therapeutics
  • IBSA Group
  • Icahn School of Medicine at Mount Sinai
  • Ichnos Glenmark Innovation
  • Icon
  • IconOVir Bio
  • IDEAYA Biosciences
  • Idorsia
  • IDT Biologika
  • IGM Biosciences
  • Ikena Oncology
  • Iksuda Therapeutics
  • ILiAD Biotechnologies
  • Image Analysis
  • ImaginAb
  • Imeka
  • IMIDomics
  • Immedica
  • Immix Biopharma
  • ImmPACT Bio
  • Immune-Onc Therapeutics
  • Immuneering
  • ImmuneOnco Biopharmaceuticals
  • Immune Regulation
  • ImmuNext
  • Immunic
  • Immunicom
  • Immunis
  • ImmunityBio
  • ImmunoBrain Checkpoint
  • Immunocore
  • ImmunoForge
  • ImmunoGen
  • ImmunoGenesis
  • Immunome
  • Immunomedics
  • ImmunoPrecise Antibodies
  • Immusoft
  • Immutep
  • Immuthera
  • ImmVira
  • IMPACT-AML
  • IMPACT Therapeutics
  • Imperial College London
  • Imugene
  • IMV
  • INADcure Foundation
  • InCarda Therapeutics
  • IncellDx
  • Incyclix Bio
  • Incyte
  • Indapta Therapeutics
  • InDex Pharmaceuticals
  • Indiana Biosciences Research Institute
  • iNGENu
  • Inivata
  • Inmagene Biopharmaceuticals
  • INmune Bio
  • Innate Pharma
  • Innolake Biopharm
  • Innosuisse
  • Innovare
  • Innovate UK
  • Innovative Cellular Therapeutics
  • Innovative Molecules
  • Innovent Biologics
  • Inotrem
  • Inovio
  • Inserm
  • Insilico Medicine
  • Inspirna
  • Instil Bio
  • Institut Bergonie
  • Institut Curie
  • Institute for Follicular Lymphoma Innovation
  • Institute of Cancer Research
  • Institute of Human Virology
  • Institute of Molecular Biology of Paraná (IBMP)
  • Institut Gustave Roussy
  • Institut Pasteur
  • Intact Therapeutics
  • Intas Pharmaceuticals
  • IntelGenx
  • Intensity Therapeutics
  • International Vaccine Institute (IVI)
  • Intract Pharma
  • Intrommune Therapeutics
  • Inventiva
  • InxMed
  • IO Biotech
  • Iolyx Therapeutics
  • iOnctura
  • Ionetix
  • Ionis Pharmaceuticals
  • Ionova
  • IPMC
  • Ipsen
  • IQVIA
  • iRenix Medical
  • IriSys
  • IRLAB
  • Ischemix
  • Isofol Medical
  • ISOThrive
  • Isotopia Molecular Imaging
  • Israeli National Authority for Technological Innovation
  • Italfarmaco
  • Italian Association for the Study of Pancreas
  • Italian Government
  • iTeos Therapeutics
  • Iterion Therapeutics
  • ITM Isotopen Technologien
  • iVeena Delivery Systems
  • Ixaka
  • IXICO
  • Jacobio Pharma
  • Jacobio Pharmaceuticals
  • Jaguar Health
  • JanOne
  • Janssen Biotech
  • Janssen Pharmaceuticals
  • Janssen Pharmaceutica NV
  • Janssen Research & Development
  • Janux Therapeutics
  • Japan Government
  • Japan Tobacco
  • Jasper Therapeutics
  • Jazz Pharmaceuticals
  • JCR Pharmaceuticals
  • jCyte
  • Jemincare
  • Jenner Institute
  • Jesse's Journey
  • Jiangsu Aosaikang Pharmaceutical
  • Jiangsu Hansoh Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Jiangsu QYuns Therapeutics
  • Jiangsu Wuzhong Pharmaceutical
  • Ji Xing Pharmaceuticals
  • JMT-Bio
  • Johns Hopkins University
  • Johnson & Johnson
  • Joincare Pharmaceutical
  • Journey Medical
  • Joyo Pharmatech
  • Jumpcan Pharmaceutical
  • Juniper Biosciences
  • Juno Therapeutics
  • Junshi Biosciences
  • Juvenile Diabetes Research Foundation
  • JW Pharmaceutical
  • JW Therapeutics
  • Kabuki Syndrome Foundation
  • Kaerus Bioscience
  • Kaigene
  • Kairos Pharma
  • Kaken Pharmaceutical
  • Kalbe Genexine Biologics
  • Kaleido Biosciences
  • Kali Therapeutics
  • KaliVir Immunotherapeutics
  • Kalos Medical
  • KalVista Pharmaceuticals
  • Kanazawa University
  • Kaneka
  • KARE Biosciences
  • Karis Bio
  • Karolinska Institute
  • Kartos Therapeutics
  • Karuna Therapeutics
  • Karyopharm Therapeutics
  • Kashiv BioSciences
  • Kazia Therapeutics
  • KBP BioSciences
  • KdT Ventures
  • Keck School of Medicine of USC
  • Kelun-Biotech Biopharmaceutical
  • Kennedy Krieger Institute
  • Keros Therapeutics
  • Kestrel Therapeutics
  • Ketabon
  • KeyBioScience
  • Keymed Biosciences
  • Kezar Life Sciences
  • KGK Science
  • Kiadis Pharma
  • Kineta
  • Kiniksa Pharmaceuticals
  • Kinnate Biopharma
  • Kintor
  • Kiora Pharmaceuticals
  • Kiromic Biopharma
  • Kissei Pharmaceutical
  • Kite Pharma
  • Koneksa Health
  • Korea Drug Development Fund
  • Kowa
  • Krankenhaus Nordwest
  • KSQ Therapeutics
  • Kukbo
  • Kumquat Biosciences
  • Kura Oncology
  • KVK-Tech
  • Kwangdong Pharmaceutical
  • Kyorin Pharmaceutical
  • Kyoto University
  • Kyowa Hakko Kirin
  • Kyowa Hakko Kogyo
  • Kyverna Therapeutics
  • LabConnect
  • Laboratoires Thea
  • Laboratorios Farmaceuticos Rovi
  • Laekna
  • LakePharma
  • Landos Biopharma
  • LaNova Medicines
  • Lantern Pharma
  • Lantheus Holding
  • Lantheus Medical Imaging
  • Launch Therapeutics
  • LaunXP Biomedical
  • Laurus Labs
  • Lava Therapeutics
  • Laxisam
  • Lee's Pharmaceutical
  • Lee Moffitt Cancer Center
  • Legend Biotech
  • LegoChem Biosciences
  • Lehigh Valley Health Network
  • Leiden University
  • Leios Therapeutics
  • LENZ Therapeutics
  • Leona M and Harry B Helmsley Charitable Trust
  • LEO Pharma
  • Lepu Biopharma
  • Les Laboratoires Servier
  • Leucid Bio
  • Leukemia & Lymphoma Society
  • Levolta Pharmaceuticals
  • LEXEO Therapeutics
  • Lexicon Pharmaceuticals
  • LG Chem
  • LianBio
  • LIB Therapeutics
  • LifeArc
  • Ligand Pharmaceuticals
  • LimmaTech Biologics
  • Lindis Biotech
  • Lineage Cell Therapeutics
  • Link Health
  • Link Immunotherapeutics
  • LinKinVax
  • Linnaeus Therapeutics
  • Lipidor
  • Lipomedix Pharmaceuticals
  • Lisata Therapeutics
  • Lixte Biotechnology
  • Longeveron
  • Lonza
  • LOTTE Biologics
  • Lotus Pharmaceuticals
  • Lucy Biotech
  • LumiThera
  • Lumos Pharma
  • Lundbeck
  • Lung Cancer Initiative
  • Lung Therapeutics
  • Lupus Therapeutics
  • Lyell Immunopharma
  • Lyndra Therapeutics
  • Lynk Pharmaceuticals
  • Lysogene
  • Lysosomal Therapeutics
  • Lytix Biopharma
  • Lyvgen Biopharma
  • Mabwell Bioscience
  • Macrogenics
  • Made Scientific
  • Madrigal Pharmaceuticals
  • Magenta Therapeutics
  • MAIA Biotechnology
  • Mapp Biopharmaceutical
  • Marker Therapeutics
  • Maruho
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology
  • Mass General Brigham
  • Matrix Biomed
  • Matrix Medical Network
  • Maverick Therapeutics
  • Max Biopharma
  • Maxcyte
  • MaxiVAX
  • Mayo Clinic
  • Maze Therapeutics
  • McQuade Center for Strategic Research and Development
  • MD Anderson Cancer Center
  • Medac
  • Medexus Pharmaceuticals
  • Mediar Therapeutics
  • Medical Research Council
  • Medical Technology Enterprise Consortium
  • Medicenna Therapeutics
  • Medicines Development for Global Health
  • Medicines Patent Pool Foundation
  • MediciNova
  • Medidata Solutions
  • MediLink Therapeutics
  • Medivir
  • MediWound
  • Medsenic
  • MEI Pharma
  • Melinta Therapeutics
  • Melior Pharmaceuticals
  • Memorial Sloan Kettering Cancer Center
  • Memo Therapeutics
  • Menarini
  • Mendus
  • Merakris Therapeutics
  • Merck and Co
  • Merck KGaA
  • Merck Sharpe & Dohme
  • Mereo BioPharma
  • Merus
  • Mesoblast
  • ME Therapeutics
  • Metsera
  • Michael J Fox Foundation
  • Michigan Medicine
  • Microbion
  • Microbio Shanghai
  • Microbiotica
  • Micron Biomedical
  • MiMedx
  • Minaris Regenerative Medicine
  • MindMaze
  • Minerva Neurosciences
  • Minghui Pharmaceutical
  • Ministry of Health
  • Ministry of Health (Israel)
  • Ministry of Health
  • Labor and Welfare
  • MiNK Therapeutics
  • Minoryx Therapeutics
  • Miralogx
  • Mira Pharmaceuticals
  • Mirati Therapeutics
  • Mirror Biologics
  • Mirum Pharmaceuticals
  • Mission Therapeutics
  • MMS
  • Moderna
  • Moleculin Biotech
  • Molnlycke Health Care
  • Molteni Farmaceutici
  • Monopar Therapeutics
  • Montefiore Health System
  • Monte Rosa Therapeutics
  • Montreal Heart Institute
  • MoonLake Immunotherapeutics
  • MorphoSys
  • Mosaic Therapeutics
  • MSD
  • MS Pharma
  • MThera Pharma
  • Multidisciplinary Association for Psychedelics Studies
  • Mustang Bio
  • Mydecine Group
  • Myovant Sciences
  • Myung In Pharm
  • Nacuity Pharmaceuticals
  • Nanjing Hanxin Pharmaceutical Technology
  • Nanjing Leads Biolabs
  • Nanobiotix
  • Nanoform
  • NanoMab Technology
  • NanoVibronix
  • Nantes University
  • NantKwest
  • NASA
  • Nascent Biotech
  • Natera
  • National Brain Tumor Society
  • National Cancer Center
  • National Cancer Institute
  • National Cheng Kung University
  • National Eye Institute
  • National Heart
  • Lung and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Child Health and Human Development
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging
  • National Institute on Drug Abuse (NIDA)
  • National Institutes of Health
  • National Research Council Canada
  • National Research Council of Canada
  • National University Cancer Institute
  • Navega Therapeutics
  • Naveris
  • Navitor Pharmaceuticals
  • NCK
  • NEC
  • Nectin Therapeutics
  • Nektar Therapeutics
  • Nelum Pharma
  • Neogenomics
  • NeoImmuneTech
  • Neoleukin Therapeutics
  • NeoLumina Bioscience
  • Neopharmed Gentili
  • Nephron Pharmaceuticals
  • NervGen Pharma
  • Nestle Health Science
  • NETRIS Pharma
  • Neumentum
  • Neupharma
  • NeuraLight,
  • Neurimmune Therapeutics
  • Neurizon Therapeutics
  • NeurMedix
  • NeuroBiogen
  • NeuroBo Pharmaceuticals
  • Neurocrine Biosciences
  • NeuroFront
  • Neurogastrx
  • NeuroGenesis
  • Neurolixis
  • Neurona Therapeutics
  • NeurOp
  • NeuroRx
  • NeuroSense Therapeutics
  • Neurotrope BioScience
  • NewAmsterdam Pharma
  • NewG Lab
  • New Hope Research Foundation
  • Newron Pharmaceuticals
  • Newsoara Biopharma
  • New York Cancer & Blood Specialists
  • New York University
  • New York University Langone Health
  • Nexcella
  • Neximmune
  • NextCure
  • NEXT Oncology
  • NFL Biosciences
  • NGM Biopharmaceuticals
  • Nicox
  • Nielsen BioSciences
  • NiKang Therapeutics
  • NImmune Biopharma
  • Nippon Shinyaku
  • NKGen Biotech
  • NKMax America
  • Nogra Pharma
  • Nordic Society of Gynaecological Oncology
  • NorthStar Medical Radioisotopes
  • Northway Biotechpharma
  • Northwell Health
  • Northwest Biotherapeutics
  • Northwestern University
  • Norwegian Cancer Society
  • Notable Labs
  • Nouscom
  • NovalGen
  • NovaQuest
  • Novaremed
  • Novartis
  • Novasep
  • Novatim Immune Therapeutics
  • Novavax
  • Novellus Biopharma
  • Novelty Nobility
  • Noveome Biotherapeutics
  • Novocure
  • Novogene
  • Novo Nordisk
  • Novotech
  • Now Biopharma
  • Noxopharm
  • NRx Pharmaceuticals
  • Nuance Pharma
  • Nucleus RadioPharma
  • Numab
  • Nurix Therapeutics
  • Nuvalent
  • Nuvation Bio
  • Nuvectis Pharma
  • Nuvisan Pharma Services
  • Nxera Pharma
  • Nykode Therapeutics
  • NYU Grossman School of Medicine for Preclinical and Clinical Research
  • NYU Langone Medical Center
  • Oak Hill Bio
  • Oasmia Pharmaceutical
  • OBI Pharma
  • Oblato
  • ObsEva
  • Octapharma
  • Ocugen
  • Oculis
  • Ocuphire Pharma
  • Odeon Therapeutics
  • Olatec Therapeutics
  • Olema Oncology
  • Oligomerix
  • OliX Pharmaceuticals
  • Ology Bioservices
  • Omeros
  • OmniaBio
  • OmniScience
  • Ona Therapeutics
  • Onco360
  • OncoC4
  • Oncoceutics
  • Oncoheroes Biosciences
  • OncoHost
  • OncoImmune
  • Oncologie
  • Oncology Venture
  • Oncolytics Biotech
  • OncoNano Medicine
  • OncoResponse
  • OncoSec Medical
  • OncoVent
  • OncoZenge
  • OncXerna Therapeutics
  • Oneness Biotech
  • OnKure
  • ONL Therapeutics
  • Ono Pharmaceutical
  • Onxeo
  • OpGen
  • OPKO Health
  • Optimi Health
  • Oragenics
  • Orano Med
  • Organon
  • Organovo
  • Orgenesis
  • ORIC Pharmaceuticals
  • Orient EuroPharma
  • Orion
  • Orsenix
  • OrsoBio
  • Orum Therapeutics
  • Oryzon
  • Oscotec
  • OSE Immunotherapeutics
  • Osel
  • Osivax
  • OS Therapies
  • Otsuka
  • Ottawa Health Research Institute
  • Ottawa Hospital Research Institute
  • Ouro Medicines
  • Overland ADCT BioPharma
  • Overland Pharmaceuticals
  • Ovid Therapeutics
  • Owl Therapeutics
  • Oxford BioMedica
  • Oxford BioTherapeutics
  • Pacira Biosciences
  • Pacylex
  • Palisade Bio
  • Palleon Pharmaceuticals
  • Panbela Therapeutics
  • Panolos Bioscience
  • PanOptica
  • PanTher Therapeutics
  • Paragon Biosciences
  • Parexel
  • Parexel Biotech
  • Parkinson's UK
  • Parthenon Therapeutics
  • Partnership for Accelerating Cancer Therapies
  • Partner Therapeutics
  • Pascal Biosciences
  • Pasithea Therapeutics
  • Passage Bio
  • PathAI
  • Pathalys Pharma
  • Pathos AI
  • PaxMedica
  • PDS Biotechnology
  • PellePharm
  • Peptilogics
  • Percheron Therapeutics
  • Perfuse Therapeutics
  • Persephone Biosciences
  • Personalis
  • Peter MacCallum Cancer Institute
  • Pfizer
  • Phanes Therapeutics
  • Pharco Pharma
  • Pharm-Olam International
  • PharmAbcine
  • Pharmaceutical Solutions
  • PharmaLogic
  • Pharmanovia
  • Pharma Two B
  • PhaseBio Pharmaceuticals
  • Phathom Pharmaceuticals
  • Phebra
  • Phenex
  • Philochem
  • Philogen
  • Phio Pharmaceuticals
  • Phosplatin Therapeutics
  • Phost’in Therapeutics
  • Photys Therapeutics
  • PhysIQ
  • Pieris Pharmaceuticals
  • Pierre Fabre
  • Pinteon Therapeutics
  • Pionyr Immunotherapeutics
  • Piramal
  • Plexxikon
  • Pluristem Therapeutics
  • Plus Therapeutics
  • PlusVitech
  • PMV Pharma
  • PoC Capital
  • POINT Biopharma
  • Polaris Group
  • PoloMar Health
  • Polpharma
  • Polymed Biopharmaceuticals
  • Polyphor
  • PolyPid
  • Poolbeg Pharma
  • Population Health Research Institute
  • Portage Biotech
  • Poseida Therapeutics
  • Poxel
  • PPD
  • Precirix
  • Precision BioSciences
  • Precision for Medicine
  • Prelude Therapeutics
  • Prenosis
  • Presage Biosciences
  • Prestige BioPharma
  • Prilenia Therapeutics
  • Prime Therapeutics
  • Primevera Therapeutics
  • Privo Technologies
  • Procare Health
  • Processa Pharmaceuticals
  • Progenetics
  • Progenics Pharmaceuticals
  • Project to Accelerate New Treatments for Tuberculosis
  • Prolium Bioscience
  • Prometheus Biosciences
  • Prometrika
  • Propanc Biopharma
  • Propella Therapeutics
  • ProQR Therapeutics
  • Protagonist Therapeutics
  • Prothena
  • Provention Bio
  • Providence
  • Providence Cancer Institute
  • Providence Therapeutics
  • PSI CRO
  • Psyence Biomedical
  • Psyence Group
  • Psyence Therapeutics
  • PT Bio Farma
  • PTC Therapeutics
  • Pulmokine
  • Pulmotect
  • Puma Biotechnology
  • PureTech Health
  • Purple Biotech
  • Q-linea AB
  • Q32 Bio
  • QBiotics
  • QED Therapeutics
  • QIAGEN
  • Qilu Pharmaceutical
  • QSAM Biosciences
  • Qualigen
  • QuantHealth
  • QuantumCell
  • Quantum Leap Health Care Collaborative
  • Quartesian Clinical Research
  • Queensland Institute of Medical Research (QIMR)
  • Quotient
  • QurAlis
  • Qurient
  • R-Pharm
  • Race Oncology
  • Radiance Biopharma
  • Radiomedix
  • Radiopharm Theranostics
  • Radius Health
  • Raiden Science Foundation
  • Rain Oncology
  • Rakuten Medical
  • Rambam Medical Center
  • Rancho Santa Fe Bio
  • Rapport Therapeutics
  • RAPT Therapeutics
  • Rasayana Therapeutics
  • Ratio Therapeutics
  • RayzeBio
  • Raziel Therapeutics
  • Re-Vana Therapeutics
  • ReAlta Life Sciences
  • Reata Pharmaceuticals
  • RecensMedical
  • Recipharm
  • Recordati
  • RedHill Biopharma
  • Redx Pharma
  • RefleXion Medical
  • Regenerative Medicine of Latin America
  • Regeneron Pharmaceuticals
  • Regenexx
  • Regenxbio
  • Regio Biosciences
  • Regnum
  • Regor Therapeutics
  • Regulus Therapeutics
  • Relay Therapeutics
  • Relief Therapeutics
  • Relife
  • Relmada Therapeutics
  • RemeGen
  • Remix Therapeutics
  • Renexxion
  • Rentschler Biotechnologie
  • Repare Therapeutics
  • Replimune
  • ReproCell
  • Reset Pharmaceuticals
  • Res Nova Bio
  • Respira Therapeutics
  • Restore Vision
  • Resverlogix
  • Resyca
  • Retinagenix
  • Revance Therapeutics
  • Reveal Genomics
  • ReveraGen BioPharma
  • reViral
  • Revive Therapeutics
  • Revolo Biotherapeutics
  • Revolution Medicines
  • Rgene
  • Rhizen Pharmaceuticals
  • Rho
  • Rhythm Pharmaceuticals
  • Ribomic
  • Ribon Therapeutics
  • Rigel Pharmaceuticals
  • Ripple Therapeutics
  • Rising Pharmaceuticals
  • Rivus Wellness and Research Institute
  • RLS
  • Roche
  • Roche Diagnostics
  • Rocket Pharmaceuticals
  • Roivant Sciences
  • Rokote Laboratories
  • Romanian National Institute of Infectious Diseases
  • Roots Pharmaceutical
  • RoslinCT
  • Roswell Park Cancer Institute
  • Royal Marsden Hospital
  • Royalty Pharma
  • RTW Investments
  • Rubicon Research
  • Rugen Therapeutics
  • Rune Labs
  • Russian Direct Investment Fund
  • Rutgers University
  • Rxilient Biotech
  • Ryvu Therapeutics
  • Rznomics
  • S.Biomedics
  • SAB Biotherapeutics
  • Salarius Pharmaceuticals
  • SAMIL Pharmaceuticals
  • Samsung Biologics
  • Sandoz
  • Saniona
  • Sanofi
  • SaNOtize Research and Development
  • Santen Pharmaceutical
  • Santhera Pharmaceuticals
  • Sapience Therapeutics
  • Sapu Bioscience
  • Sarah Cannon Research Institute
  • Sarepta Therapeutics
  • Savara Pharma
  • Scancell
  • Scandion Oncology
  • SciClone Pharmaceuticals
  • Science 37
  • ScienceMachine
  • Scilex Holding
  • Scipher Medicine
  • Sciwind Biosciences
  • Scripps Research Institute
  • Scynexis
  • Seagen
  • Seattle Genetics
  • Sebela Pharmaceuticals
  • Second Genome
  • Secretome Therapeutics
  • Seikagaku
  • Selecta Biosciences
  • SELLAS Life Sciences Group
  • Sema4
  • Sen-Jam Pharmaceutical
  • Senhwa Biosciences
  • Senju Pharmaceutical
  • Sensei Biotherapeutics
  • Sentynl Therapeutics
  • Seoul National University
  • Sequel Med Tech
  • SERB Pharmaceuticals
  • Seres Therapeutics
  • Sermonix Pharmaceutical
  • Sernova
  • Serum Institute of India
  • Sesen Bio
  • Seven and Eight Biopharmaceuticals
  • SevenScore Pharmaceuticals
  • Seyltx
  • SFJ Pharmaceuticals
  • Shanghai Argo Biopharmaceutical
  • Shanghai ChemPartner
  • Shanghai Haini Pharmaceutical
  • Shanghai Lishan Biopharmaceuticals
  • Shanghai Public Health Clinical Centre
  • Sharp HealthCare
  • Shasqi
  • Shenzhen Chipscreen Biosciences
  • Shenzhen Kangtai Biological Products
  • Shenzhen Salubris Pharmaceuticals
  • Shionogi
  • Shirley Ryan AbilityLab
  • SIGA Technologies
  • Sigyn Therapeutics
  • Silexion Therapeutics
  • Silk Road Therapeutics
  • Simcere Pharmaceutical
  • Simcere Zaiming
  • Simcha Therapeutics
  • Singlomics Biopharmaceuticals
  • Singota Solutions
  • Sino Biopharmaceutical
  • SinoMab Bioscience
  • Sinopharm Group Beijing HuaHong
  • Sinovac Biotech
  • Sintetica
  • Sionna Therapeutics
  • Sirnaomics
  • SIRS Therapeutics
  • Sirtex Medical
  • Skane University Hospital
  • SK Biopharmaceuticals
  • SK Bioscience
  • Skye Bioscience
  • SmartCella
  • Smerud Medical Research
  • Societal CDMO
  • Sol-Gel
  • Solasia Pharma
  • Solid Biosciences
  • Soligenix
  • Somite Therapeutics
  • Sonnet BioTherapeutics
  • Sonoma BioTherapeutics
  • Sorrento Therapeutics
  • Sorse Technology
  • Sosei
  • Sosei Heptares
  • SOTIO
  • Sparrow Pharmaceuticals
  • Specialised Therapeutics
  • SpectronRx
  • Spectrum Pharmaceuticals
  • Sperogenix Therapeutics
  • Spero Therapeutics
  • Spinogenix
  • SpotitEarly
  • Spring Bank Pharmaceuticals
  • SpringWorks Therapeutics
  • Spruce Biosciences
  • Stalicla
  • Stanford University
  • Stanford University School of Medicine
  • Starton Therapeutics
  • Statera Biopharma
  • St Elizabeth Healthcare
  • SteroTherapeutics
  • Stimunity
  • Stoke Therapeutics
  • Storm Therapeutics
  • Strados Labs
  • Strata Oncology
  • Streeterville Capital
  • Structure Therapeutics
  • Stuart Therapeutics
  • Sumitomo Pharma America
  • Sumitomo Pharmaceuticals
  • Summit Therapeutics
  • Sunovion Pharmaceuticals
  • Sun Pharmaceutical
  • Sunshine Lake Pharma
  • Sunstone Therapies
  • Supernus Pharmaceuticals
  • Supriya Lifescience
  • Surface Oncology
  • Sutro Biopharma
  • Suzhou Puhe BioPharma
  • Suzhou Ribo Life Sciences
  • Suzhou Sinovent Pharmaceuticals
  • Suzhou Siran Biotechnology
  • Swedish Orphan Biovitrum
  • Swedish Research Council
  • Swing Therapeutics
  • Symbiosis
  • Synairgen
  • Synaptogenix
  • Syndax Pharmaceuticals
  • Syneos Health
  • Synhale Therapeutics
  • Synimmune
  • Synlogic
  • Synnovation Therapeutics
  • Syntactx
  • Synthekine
  • Syros Pharmaceuticals
  • Systimmune
  • T-Cure Bioscience
  • T-MAXIMUM Biotech
  • Tabuk Pharmaceutical
  • Tachyon Therapeutics
  • TaiGen Biotechnology
  • Taiho
  • Taisho Pharmaceutical
  • Taiwan Bio Therapeutics
  • Taiwan Tanabe Seiyaku
  • Takeda Pharmaceutical
  • Takeda Pharmaceuticals U.S.A
  • Tanner Pharma
  • TargetRx
  • Targovax
  • TargTex
  • Tarus Therapeutics
  • Tarveda Therapeutics
  • Tasly Pharmaceuticals
  • Tavotek Biotherapeutics
  • Taysha Gene Therapies
  • TCR2 Therapeutics
  • Technomark Life Sciences
  • Teitur Trophics
  • Telix Pharmaceuticals
  • Tempest Therapeutics
  • Tempus
  • Tenacia Biotechnology
  • Teon Therapeutics
  • Terns Pharmaceuticals
  • Terran Biosciences
  • TerSera Therapeutics
  • TerThera
  • Tessa Therapeutics
  • Teva Pharmaceutical Industries
  • Texas A&M Health Science Center
  • Texcell
  • TFF Pharmaceuticals
  • Tharimmune
  • Thea Open Innovation
  • The Frontiers in Congenital Disorders of Glycosylation Consortium
  • The International AIDS Vaccine Initiative
  • Therabest
  • Theragent
  • Theramex
  • Theranexus
  • Therapeutic Solutions International
  • Theratechnologies
  • Theriva Biologics
  • Therma Bright
  • Thermo Fisher Scientific
  • The United Laboratories
  • Third Arc Bio
  • Thomas Jefferson University
  • Tianjin CanSino Biotechnology
  • Tianjin JuveStar Biotech
  • TILT Biotherapeutics
  • TiumBio
  • Tivic Health Systems
  • Tiziana Life Sciences
  • TJ Biopharma
  • Tolerance Bio
  • Tolero Pharmaceuticals
  • Tolmar
  • TONIX Pharmaceuticals
  • Torii Pharmaceutical
  • TRACT Therapeutics
  • Transcenta
  • Transgene
  • TransThera
  • Travere Therapeutics
  • TreeFrog Therapeutics
  • Treeway
  • Trethera
  • Trevena
  • TrialSpark
  • TRIGR Therapeutics
  • Trinity Pharmaceuticals
  • TriSalus Life Sciences
  • Triumvira Immunologics
  • TRPharm
  • Tryp Therapeutics
  • TScan Therapeutics
  • Tufts Medical Center
  • TuHURA Biosciences
  • Turning Point Therapeutics
  • TWi Biotechnology
  • TYG Oncology
  • Tyligand Bioscience
  • Tyme Technologies
  • UbiVac
  • UCB
  • UgeneX Therapeutics
  • UK Government
  • Ultragenyx Pharmaceuticals
  • UMass Chan Medical School
  • UMass Memorial Medical Center
  • Undisclosed Company
  • Unicycive Therapeutics
  • UNION Therapeutics
  • UniQure
  • United BioPharma
  • UnitedHealth
  • University of Alabama at Birmingham
  • University of Alberta
  • University of Auckland
  • University of Birmingham
  • University of Calgary
  • University of California
  • Davis
  • University of California Los Angeles
  • University of Cambridge
  • University of Colorado
  • University of Florida
  • University of Kansas
  • University of Michigan
  • University of Minnesota
  • University of Nebraska
  • University of North Carolina
  • University of Oxford
  • University of Pennsylvania
  • University of Pittsburgh Medical Center
  • University of Rochester
  • University of Rochester Medical Center
  • University of Saskatchewan
  • University of Sheffield
  • University of Sydney
  • University of Washington
  • University of Wisconsin
  • University of Wisconsin-Madison
  • Unlearn
  • Urica Therapeutics
  • UroGen Pharma
  • US Army Medical Research and Material Command
  • US Government
  • Usher Syndrome Coalition
  • US Oncology
  • Utrecht University
  • Vaccibody
  • Vaccinex
  • Vaccitech
  • Validus Pharmaceuticals
  • Valneva
  • Valo Therapeutics
  • Vancouver Infectious Diseases Centre
  • Vanda Pharmaceuticals
  • Vanderbilt University
  • Vaneltix Pharma
  • Vasomune Therapeutics
  • Vaxart
  • Vaximm
  • Vaxxinity
  • VBI Vaccines
  • VectivBio
  • Vedanta Biosciences
  • Veeva Systems
  • Vega Therapeutics
  • VenatoRx
  • Ventyx Biosciences
  • Veralox Therapeutics
  • Verastem
  • Vera Therapeutics
  • Verdiva Bio
  • Verge Genomics
  • Vergent Bioscience
  • Verily
  • VerImmune
  • Verismo Therapeutics
  • Verona Pharma
  • Verrica Pharmaceuticals
  • Vertex Pharmaceuticals
  • Veru
  • VGI Health Technology
  • Vial
  • Viatris
  • Vicore Pharma
  • Viewpoint Molecular Targeting
  • Vifor Pharma
  • Vigil Neuroscience
  • Viking Therapeutics
  • Vincera Pharma
  • Viracta Therapeutics
  • Vir Biotechnology
  • Virginia Catalyst
  • Viridian Therapeutics
  • VistaGen Therapeutics
  • Vitalli Bio
  • Vivet Therapeutics
  • Vividion Therapeutics
  • Vor Bio
  • vTv Therapeutics
  • Vyluma
  • Vyriad
  • Wacker Biotech
  • Wacker Chemie
  • Waiv
  • Walgreens
  • Walter and Eliza Hall Institute
  • Warpnine
  • WaVe Lifesciences
  • WAVE Life Sciences
  • Weill Cornell Medical College
  • Weizmann Institute
  • Wellcome Trust
  • Wellmarker Bio
  • Werewolf Therapeutics
  • WestGene Biopharma
  • Wigen Biomedicine
  • Windtree Therapeutics
  • Windward Bio
  • Winhealth Pharma Group
  • Wisconsin Alumni Research Foundation
  • Worldwide Clinical Trials
  • WPD Pharmaceuticals
  • WUGEN
  • WuXi Advanced Therapies
  • Wuxi Apptec Laboratory Services
  • WuXi Biologics
  • Wuxi STA
  • WuXi XDC
  • XBiotech
  • Xcellbio
  • Xencor
  • Xenetic Biosciences
  • Xenon Pharmaceuticals
  • Xequel Bio
  • Xiamen Amoytop Biotech
  • Xilio Therapeutics
  • Xlife Sciences
  • XNK Therapeutics
  • Xoma
  • Xortx Therapeutics
  • Xuanzhu Biopharma
  • XyloCor Therapeutics
  • Yale University
  • Yamo Pharmaceuticals
  • Yarrow Bioscience
  • Yatiri Bio
  • Yeda Research and Development Company
  • Yingli Pharma
  • Yisheng Biopharma
  • Yumanity Therapeutics
  • Yunnan Walvax Biotech
  • Zai Lab
  • ZAI Laboratory
  • Zambon
  • Zealand Pharma
  • Zedira
  • Zelgen
  • Zenas BioPharma
  • Zenith Epigenetics
  • Zentalis Pharmaceuticals
  • Zenyaku Kogyo
  • Zetagen Therapeutics
  • Zhaoke (Hong Kong) Ophthalmology Pharmaceutical
  • Zhejiang Conba Pharmaceutical
  • Zhejiang Doer Biotechnology
  • Zhittya Genesis Medicine
  • Zifo
  • Zion Medical
  • Zion Pharmaceuticals
  • Zumutor Biologics
  • Zura Bio
  • Zydus Cadila
  • Zydus Lifesciences
  • Zylo Therapeutics
  • Zymedi
  • Zymeworks
  • ZYUS Life Sciences
  • ZyVersa Therapeutics
  • ZZ Biotech

Methodology

  • The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
  • The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
  • The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
  • The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
  • The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

The publisher provides comprehensive coverage of the following partnering or deal types:

  • Asset purchase
  • Assignment
  • Co-development
  • Co-market
  • Co-promotion
  • Collaborative R&D
  • Contract service
  • CRADA
  • Cross-licensing
  • Development
  • Distribution
  • Equity purchase
  • Evaluation
  • Grant
  • Joint venture
  • Licensing
  • Loan
  • Manufacturing
  • Marketing
  • Option
  • Promotion
  • Research
  • Royalty financing
  • Settlement
  • Spin out
  • Sub license
  • Supply
  • Termination
  • Warrant

Every deal record is fully categorized and includes the following data, where available:

  • Industry sector
  • Therapy areas
  • Technology type
  • Deal components
  • Financial terms
  • Stage of development
  • Exclusivity
  • Asset type
  • Geographic focus
  • Excluded geography
  • Company press release
  • SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

 

 

Loading
LOADING...

Related Topics

Related Reports

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026 - Product Image

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026

  • Report
  • 1500 Pages
  • Global
From
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026 - Product Image

Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026

  • Report
  • 2500 Pages
  • Global
From
Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031 - Product Image

Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031

  • Report
  • 960 Pages
  • Global
From
Global Multispecific Antibodies Market Size, Antibodies Sales, Dosage, Patent, Price, Proprietary Technologies & Clinical Trials Insight 2031 - Product Image

Global Multispecific Antibodies Market Size, Antibodies Sales, Dosage, Patent, Price, Proprietary Technologies & Clinical Trials Insight 2031

  • Report
  • 1200 Pages
  • Global
From
Cell Line Characterization and Cell Line Development Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Source of Cell Line / Expression System, Application of Cell Line, Company Size, and Key Geographical Regions - Product Image

Cell Line Characterization and Cell Line Development Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Source of Cell Line / Expression System, Application of Cell Line, Company Size, and Key Geographical Regions

  • Report
  • 455 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.